Finance

Lists
R1MD34:BVMF
Resmed Inc Bdr
R$243,85
+0,23%
(+0,57) 1D
23 Jul., 11:58:35 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for R1MD34...
Mkt. cap
32,35 mjd
Avg. vol.
0,00
Volume
0,00
52-wk high
R$373,88
52-wk low
R$242,17
Shares outstanding
140,64 m
No. of employees
11 k
Mkt. cap
32,35 mjd
Avg. vol.
0,00
Volume
0,00
52-wk high
R$373,88
52-wk low
R$242,17
Shares outstanding
140,64 m
No. of employees
11 k
News stories
From web sources and news partners
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed Inc Bdr
CEOMichael J. Farrell
Employees11,4 k
FoundedJun. 1989
HeadquartersSan Diego, Kalifornië, Verenigde State van Amerika
SectorMedical device
Websiteresmed.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,34 mjd
1,42 mjd
1,43 mjd
1,46 mjd
Cost of goods sold
506,94 m
536,28 m
532,58 m
594,13 m
Cost of revenue
506,94 m
536,28 m
532,58 m
594,13 m
Research and development expenses
87,32 m
90,97 m
94,27 m
105,72 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
259,19 m
275,70 m
279,80 m
293,36 m
Operating expense
366,29 m
386,24 m
393,16 m
417,88 m
Total operating expenses
873,24 m
922,51 m
925,74 m
1,01 mjd
Operating income
462,35 m
500,30 m
505,67 m
451,64 m
Other non operating income
-3,84 m
42,00 k
181,00 k
4,40 m
EBT including unusual items
446,79 m
496,15 m
502,31 m
474,16 m
EBT excluding unusual items
468,79 m
504,48 m
518,30 m
476,09 m
Income tax expense
98,26 m
103,56 m
103,58 m
90,73 m
Effective tax rate
21,99%
20,87%
20,62%
19,14%
Other operating expenses
-
-
-
-
Net income
348,54 m
392,59 m
398,73 m
383,43 m
Net profit margin
26,10%
27,59%
27,86%
26,20%
Earnings per share
2,55
2,81
0,29
0,30
Interest and investment income
4,69 m
4,46 m
3,80 m
31,76 m
Interest expense
-
-
-
-
Net interest expenses
4,69 m
4,46 m
3,80 m
31,76 m
Depreciation and amortization charges
-
-
-
-
EBITDA
503,64 m
543,79 m
558,22 m
490,13 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme